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Objective: Exercise may reduce morbidity, increase survival, and improve quality of life (QoL)
in prostate cancer patients. However, effective ways to encourage exercise outside carefully con-
trolled clinical trials remain uncertain. We evaluated the effectiveness of peer‐led self‐manage-
ment for increasing exercise participation in men with localized prostate cancer.
Methods: Four hundred and sixty‐three prostate cancer patients from Queensland, Australia
were randomized to a monthly telephone‐based group peer support for 6 months supported by
self‐management materials and exercise equipment (INT, n = 232) or usual care (UC, n = 231).
Participants were assessed at baseline, 3, 6, and 12 months. Primary outcomes were compliance
with exercise guidelines; secondary outcomes were psychological distress and QoL.
Results: Patients in INT engaged in more resistance exercise than UC at 3 months (19.4 [95% CI
6.52 to 32.28] min/wk, P = .003) and 6 months (14.6 [95% CI 1.69 to 27.58] min/wk, P = .027); more
men achieved sufficient physical activity levels at 3 months (χ2 = 8.89, P = 0.003). There was no dif-
ference between groups for aerobic‐based activity at any time point nor for resistance exercise time
at 12‐month follow‐up. INT had higher QoL Relationships scores at 3 months (.03 [95% CI .00 to .06],
P = .038) compared with UC. Limitation included self‐reported assessment of exercise.
Conclusions: Peer‐led intervention was effective in increasing patients' resistance exercise
participation in the short‐to‐medium term and in the number of men achieving sufficient activity
levels in the short‐term; however, this was not accompanied by overall improvements in QoL or
psychological distress. Methods to increase effectiveness and maintain long‐term adherence
require further investigation.
KEYWORDS
cancer, exercise, oncology, peer support group, prostate, resistance exercisealian New Zealand Clinical Trials Registry.
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2 GALVÃO ET AL.1 | BACKGROUND
Regular exercise is associated with improved quality of life (QoL)1,2 and
lower incidence of prostate cancer (PCa) death.3-6 We2,7,8 and
others1,9,10 in tightly controlled laboratory‐based trials have shown
exercise can prevent and even reverse treatment‐related adverse
effects. However, these interventions were supervised by exercise
physiologists/specialists and so may not be widely accessible. Inter-
ventions that reach a larger number of PCa survivors independent of
geographical location and are relatively inexpensive are needed to
determine the potential of more real‐life programs to enhance exercise
participation.
Attempts have been made to improve physical activity behavior in
men with PCa using various distance‐based interventions with mixed
results. For example, the FRESH START trial showed an increase of
20 minutes of physical activity in PCa and breast cancer survivors fol-
lowing a 10‐month program of tailoredmailed materials to improve diet
and exercise behaviors.11 The LEAD trial in PCa and breast cancer sur-
vivors showed no change in physical activity behavior following a
6‐month home‐based diet and exercise program that was delivered
by telephone and print materials.12 By contrast, the RENEW trial
showed a mean group difference of 18 and 13 minutes of resistance
and aerobic exercise per week, respectively, following a 12‐month
home‐based tailored program of telephone counseling and mailed
materials promoting exercise in PCa, breast, and colorectal cancer sur-
vivors.13 Finally, the PROMOTE trial showed increases at 1 month,
but not at 3 months, in physical activity behavior following a self‐
administered implementation intention intervention (goal setting,
devising a plan to achieve goals, developing strategies to overcome
barriers) in men with PCa compared with standard physical activity
recommendations.14
Self‐management shows consistent positive effects across a range
of chronic illnesses and address issues of equity, accessibility, and
choice. Likewise, peer support has relatively high uptake among men
with PCa with men reporting that peer discussions provide informa-
tion, emotional support, and reduce feelings of social isolation. We
have also shown in PCa patients that peer discussion combined with
group education emphasizing self‐management resulted in positive
health behaviors.15 Accordingly, we examined whether a peer‐led
intervention that targeted both exercise and unmet supportive care
needs was effective for increasing exercise participation in patients
with localized PCa. Changes in exercise participation and resistance
exercise over 3, 6, and 12 months served as the primary study
endpoint. Secondary endpoints included QoL and psychological
distress.2 | METHODS
2.1 | Patients
Eligible patients were men diagnosed with localized PCa in Queensland
after 1st January 2011 and recruited through the Queensland Cancer
Registry. Inclusion criteria were: (1) have undergone or currently
undergoing PCa treatment; (2) able to read and speak English; (3) noprevious history of head injury, dementia, or psychiatric illness; (4) no
concurrent cancer; and (5) physician clearance.
2.2 | Study design and random assignment
This trial was a 2‐armed RCT with participants randomized to inter-
vention (INT) or usual care (UC).16 Randomization followed baseline
assessment and occurred in blocks of 16, with each condition ran-
domly generated 8 times within each block to ensure an unpredict-
able allocation sequence with equal numbers of men in each
condition at the completion of each block, and sufficient men to
form a telephone‐based group in the intervention condition. This
sequence was undertaken by the project manager and concealed
from investigators. The intervention was manualized with adherence
ensured through training and supervision. Ethical approval was
granted by Griffith University Human Research Ethics Committee
(PSY/F6/10/HREC) and ethics committees of public and private hos-
pitals across Queensland. The study was guided by the CONSORT
statement.172.3 | Intervention
The intervention included self‐management materials and monthly
telephone‐based group peer support for 6 months. Topics covered
included: managing treatment effects; understanding and managing
stress; physical activity; nutrition and diet; relationships; sex and inti-
macy. One of the 6 sessions focused specifically on physical activity
and peers discussed exercise at each session to check‐in with men
how their physical activity goals were progressing. Participants were
provided with an elastic exercise device (Gymstick, Finland) and a
watch with heart rate monitor (Polar, Finland) so that all men had
the basic equipment to pursue an effective exercise program. Online
web‐based material was also available to participants. After baseline
assessment, men in the intervention condition received a printed
feedback sheet with feedback about their unmet supportive care
needs, distress thermometer score, waist circumference, and exercise
levels. The aim was to assist them in identifying potential target areas
for improvement, evaluate prime concerns, and set self‐management
goals. Group peer support occurred via teleconference led by 2 peer
support volunteers. A specialist nurse counselor was present during
calls to respond to medical questions if required. Each group had
6‐8 members, and a total of 29 groups were formed. Peers were
experienced in community support and received 12 hours of training
on group dynamics, telephone‐based support, communication skills,
adjustment to cancer, managing treatment effects, sexuality and
penile rehabilitation, exercise and cancer, managing challenging
situations, and research procedures. Ongoing supervision was
provided by a PCa nurse counselor before and after every peer
group session (equivalent to 1 hour/session) and quarterly group
supervision meetings.2.4 | Usual care
Men assigned to UC received their standard medical management and
a set of published patient education materials.
FIGURE 1 CONSORT flowchart of recruitment, participation, data collection, and attrition
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4 GALVÃO ET AL.2.5 | Primary and secondary study endpoints
Study variables were assessed using validated and reliable self‐report
measures. Follow‐up assessments occurred 3, 6, and 12 months after
either the date of baseline assessment (UC) or the date of the partici-
pant's scheduled first group peer session (INT). The primary study
endpoint was sufficient activity was based on the recommended phys-
ical activity guidelines for people with cancer18 which is to accumulate
150 minutes of moderate‐intensity or 75 minutes of vigorous (or a
combination of moderate and vigorous) aerobic exercise per week, in
addition to resistance exercise sessions at least twice weekly. Related
secondary endpoints were exercise levels measured using the modified
Godin Leisure‐Time Exercise Questionnaire, to assess the mean fre-
quency and duration of mild, moderate, strenuous, and resistance exer-
cise (eg lifting weights, push ups, sit ups, and using resistance bands)
during free time in a typical week in the past month.19 Total exercise
duration (minutes) per typical week was calculated for each exercise
type and overall. Other secondary endpoints included health‐related
QoL assessed with the AQoL‐8D20, disease‐specific QoL assessed by
the International Prostate Symptom Score (IPSS)21 and symptom sub-
scales of the Expanded UCLA Prostate Cancer Index Composite
(EPIC)22,23, the Brief Symptom Inventory (BSI) to assess psychological
distress, and body weight, body mass index (BMI, kg/m2), and waist
circumference.2.6 | Remoteness area
Participants' residential suburb at diagnosis was assigned a Statisti-
cal Area 2 (SA2) region using a concordance provided by the
Australian Bureau of Statistics. Based on 2011 and 2012 data, SA2
areas were then matched to the appropriate remoteness category:
“Major city”, “Inner regional”; “Outer regional”; and “Remote and very
remote”.FIGURE 2 A, Adjusted mean resistance exercise (min) per week by
study group and timepoint. (Error bars display adjusted 95%
confidence intervals). (* = P < 0.05; ** = P < 0.01). B, Adjusted mean
AQoL relationships subscale score by study group and timepoint. (error
bars display adjusted 95% confidence intervals). (* = P < 0.05)2.7 | Statistical methods and sample size calculation
A total of 590 men were to be recruited to the study (15% attrition
from treatment; 250 men in each condition at final assessments).
Sample size was based on a Monte Carlo simulation run through
Mplus to provide 80%‐85% power to detect standardized interven-
tion effect sizes of .5 (moderate) for the dichotomous outcomes.
Power for the continuous outcomes is higher for the same sample
size based on simulations by Jo.24 For continuous variables, to detect
an effect size of 0.5 (alpha = 0.05, 2‐tailed tests, power at 80%,
and accounting for 15% attrition), a sample of only 150 men would
be required (75 per group for ~63 per group at the completion of
the study).
For continuous dependent variables, intervention effects were
examined using multilevel mixed effects linear regression in Stata
14.0 using direct maximum likelihood estimation which is consistent
with intention‐to‐treat principles. Separate linear mixed models were
used to analyze each continuous outcome variable (exercise duration,
QoL, psychological distress, weight, waist circumference, BMI), with
active treatment group and time, and group by time interaction as
fixed factors, age as covariate, and participant included as randomeffect. For these linear mixed‐effects model analyses, the reference
group was UC at study commencement (0 months). In these
analyses, the effects represent change from baseline for the treat-
ment group compared with change from baseline for the UC group.
Analyses with significant interactions were followed up by assessing
group differences at each time point.
Chi‐squared analyses assessed the frequency of participants'
adherence to physical activity guidelines, as inactive, insufficiently
active, or sufficiently active. Statistical significance was set at an alpha
level of .05.3 | RESULTS
3.1 | Patients
A total of 463 men completed baseline assessment (see Figure 1); 231
were randomized into UC and 232 into INT, with patients 10.8 months
post‐diagnosis (SD = 3.0, range = 0.6‐21.6 months). At baseline, INT
and UC did not differ significantly on any demographic or psychosocial
variable, except for age. Men in INT were significantly (P = 0.05) youn-
ger (M = 63.7 years, SD = 7.6) than men in UC (M = 65.1 years, SD = 7.8).
Mean age of all participants was 64.4 years (SD = 7.7); 84.5% were
married or in a de facto relationship, with the remainder divorced,
widowed, or single; 62% had completed trade or university educa-
tion, and the remainder high school or less schooling. Mean time
since treatment was 7.3 months (SD = 3.0); 70.4% had received a
radical prostatectomy, 12.5% received external beam radiation
GALVÃO ET AL. 5(EBRT) with androgen deprivation therapy (ADT), 3.5% EBRT with-
out ADT, 1.7% brachytherapy with ADT, 4.8% brachytherapy with-
out ADT, 1.9% EBRT and brachytherapy and ADT, 2.4% ADT only,
and 2.8% had other combinations and/or forms of treatment. Mean
waist circumference was 102.4 cm, and mean BMI was 27.9. 194
UC and 184 INT (81.6%) completed the 12‐month assessment.
Remoteness of residence was representative of the male population
aged 43‐89 years in Queensland during 2012 and of PCa patients
aged 43‐89 years diagnosed in Queensland during 2011. For INT,
their first peer group session was scheduled 2.7 weeks (SD = 1.7,
range = 0.1‐8.3) following baseline assessment. Of the 6 scheduledTABLE 1 Adjusted means and the results of multilevel mixed effects regre
variables over time compared with usual care, after controlling for age. (sig
text)
Intervention M (SE)
Baseline 3 month 6 month
Exercise duration per week
Mild exercise 142.1 (16.9) 144.2 (19.1) 137.0 (18.8)
Moderate exercise 88.2 (10.7) 122.7 (12.0) 93.9 (11.9)
Strenuous exercise 37.7 (5.8) 25.8 (6.4) 37.7 (6.4)
Resistance exercise 21.5 (4.2) 35.1 (4.8)** 33.7 (4.7)*
Total exercise 289.6 (21.5) 329.9 (24.2) 302.2 (23.9)
No. of resistance sessions 1.0 (0.1) 1.1 (0.1) 1.0 (0.1)
AQoL‐8D
Utility score .86 (.01) .87 (.01) .87 (.01)
Mental super Dim'n .54 (.01) .56 (.01) .56 (.01)
Physical super Dim'n .77 (.01) .80 (.01) .81 (.01)
Independent living .91 (.01) .92 (.01) .93 (.01)
Happiness .83 (.01) .84 (.01) .84 (.01)
Mental health .72 (.01) .72 (.01) .74 (.01)
Coping .84 (.01) .85 (.01) .84 (.01)
Relationships .84 (.01) .84 (.01)* .83 (.01)
Self‐worth .89 (.01) .90 (.01) .90 (.01)
Pain .86 (.01) .91 (.01) .92 (.01)
Senses .85 (.01) .85 (.01) .84 (.01)
BSI
Somatic 47.4 (.5) 48.7 (.5) 48.9 (.5)
Depression 46.1 (.5) 47.1 (.6) 47.2 (.6)
Anxiety 45.4 (.5) 45.1 (.6) 46.0 (.6)
Global score 45.6 (.6) 46.2 (.6) 46.6 (.6)
Weight (kg) 86.4 (.9) 86.1 (.9) 86.0 (.9)
Body mass index 27.8 (.3) 27.7 (.3) 27.7 (.3)
Waist circumference (cm) 102.1 (.7) 100.8 (.7) 100.2 (.7)
IPSS 7.3 (.4) 7.3 (.4) 6.5 (.4)
EPIC
Urinary domain 85.7 (.9) 85.2 (1.0) 87.3 (1.0)
Bowel domain 93.1 (.6) 93.1 (.7) 94.0 (.7)
Sexual domain 37.0 (1.5) 32.6 (1.6) 33.8 (1.6)
Hormonal domain 85.9 (2.0) 84.9 (1.9) 85.6 (1.8)
Int = Intervention; UC = Usual care.
*P value < .05 for post‐hoc analyses assessing group differences between INT
**P value < .01 for post‐hoc analyses assessing group differences between INTsessions, median attendance was 4 sessions (SD = 2.0, range = 0‐6);
28% of men accessed the website at least once (median = 1;
range = 1‐8) for an average time of 23 minutes (range = 1 minute
to 3.6 hours).3.2 | Exercise participation
Adjusting for age, the linear mixed‐effects model showed a significant
interaction between time and study group for resistance exercise dura-
tion (P = .048 [95% CI .15‐31.07]) at 3 months. Post‐hoc tests assessing
group differences showed that INT had significantly greater resistancession on the effect of intervention on primary and secondary outcome
nificant group differences are indicated; for significant interactions see
Usual care M (SE)
12 month Baseline 3 month 6 month 12 month
145.0 (18.9) 177.5 (16.9) 140.3 (18.0) 165.7 (18.4) 161.0 (18.5)
94.1 (11.9) 72.5 (10.7) 85.1 (11.3) 85.5 (11.5) 86.9 (11.6)
32.1 (6.3) 32.6 (5.8) 25.8 (6.1) 31.2 (6.2) 21.3 (6.2)
19.6 (4.7) 17.7 (4.2) 15.7 (4.5) 19.1 (4.6) 15.6 (4.6)
291.9 (24.0) 300.4 (21.6) 267.5 (22.9) 296.3 (23.4) 281.5 (23.5)
0.9 (0.1) 0.8 (0.1) 0.7 (0.1) 0.8 (0.1) 0.8 (0.1)
.87 (.01) .85 (.01) .85 (.01) .86 (.01) .85 (.01)
.57 (.01) .54 (.01) .54 (.01) .56 (.01) .55 (.01)
.80 (.01) .75 (.01) .79 (.01) .80 (.01) .80 (.01)
.92 (.01) .89 (.01) .91 (.01) .91 (.01) .91 (.01)
.85 (.01) .83 (.01) .83 (.01) .84 (.01) .83 (.01)
.74 (.01) .72 (.01) .72 (.01) .72 (.01) .73 (.01)
.85 (.01) .85 (.01) .84 (.01) .84 (.01) .83 (.01)
.82 (.01) .83 (.01) .81 (.01) .82 (.01) .80 (.01)
.91 (.01) .89 (.01) .90 (.01) .90 (.01) .89 (.01)
.91 (.01) .83 (.01) .89 (.01) .90 (.01) .89 (.01)
.84 (.01) .85 (.01) .84 (.01) .84 (.01) .85 (.01)
48.9 (.5) 47.5 (.5) 49.3 (.5) 48.9 (.5) 49.2 (.5)
46.9 (.6) 46.0 (.5) 47.9 (.5) 47.6 (.5) 47.9 (.6)
44.6 (.6) 44.6 (.5) 45.2 (.5) 44.9 (.5 44.6 (.5)
45.9 (.6) 45.0 (.6) 47.1 (.6) 46.3 (.6) 46.5 (.6)
86.2 (.9) 87.4 (.9) 87.8 (.9) 88.1 (.9) 88.5 (.9)
27.7 (.3) 28.0 (.3) 28.1 (.3) 28.2 (.3) 28.3 (.3)
100.9 (.7) 102.7 (.7) 102.0 (.7) 101.8 (.7) 101.9 (.7)
6.3 (.4) 7.2 (.4) 6.9 (.4) 6.6 (.4) 6.3 (.4)
87.0 (1.0) 86.7 (.9) 86.2 (1.0) 87.0 (1.0) 87.2 (1.0)
92.8 (.7) 93.9 (.6) 94.2 (.7) 93.7 (.7) 93.0 (.7)
35.2 (1.6) 37.3 (1.5) 30.8 (1.5) 33.5 (1.5) 34.1 (1.6)
86.0 (1.7) 87.0 (1.9) 83.9 (1.7) 84.8 (1.7) 85.1 (1.6)
and UC subsequent to linear mixed‐effects analyses.
and UC subsequent to linear mixed‐effects analyses.
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GALVÃO ET AL. 7exercise duration at 3 months (19.4 [95% CI 6.52‐32.28] min/wk,
P = .003) and 6 months (14.6 [95% CI 1.69‐27.58] min/wk, P = .027)
(Figure 2A). For mean values of exercise see Table 1. No other signifi-
cant interactions were found for duration of mild, moderate, strenuous,
or total exercise. There was no significant interaction between time and
study group for the number of resistance exercise sessions per week.
3.3 | Compliance with exercise guidelines
Chi‐squared analyses revealed a significant difference between the
study groups in rates of inactivity (χ2 = 6.12, P = .013) and in sufficient
physical activity (χ2 = 8.89, P = .003) at 3‐month follow‐up (Table 2).
Specifically, at 3 months, 40.3% of UC were inactive compared with
29.3% of INT, while 7.8% of UC were sufficiently active compared
with 18% for INT.
3.4 | QoL and disease‐specific QoL
Adjusting for age, there were significant interactions between time and
study group for AQoL subscales: at 3 months for the Relationship sub-
scale (P = .049); and at 12 months for the Mental Super‐Dimension
(P = .031), Happiness (P = .022), Coping (P = .02), and Self‐Worth
(P = .005) subscales. Post‐hoc tests showed that at 3‐month follow‐
up INT had significantly greater AQoL Relationships subscale scores
(.03 [95% CI .00–.06], P = .038) compared with UC (Figure 2B). No
other significant group differences were found for the AQoL. There
were no significant interactions between time and study group for
the EPIC domains or the IPSS.
3.5 | Psychological distress
At 3 months, adjusting for age, there was a significant interaction for
the global BSI score (P = .038); however, post‐hoc tests showed no sig-
nificant differences (Table 1). There were no significant interactions
among the BSI subscales.
3.6 | Weight, BMI, waist circumference, and adverse
events
At 6 and 12 months a significant interaction was found for weight
(6 months, P = .034; 12 months, P = .009) and BMI (6 months,
P = .031; 12 months, P = .009); however, post‐hoc tests did not show
significant group differences (Table 1). There was no significant inter-
action for waist circumference. There were no adverse events.4 | CONCLUSIONS
To our knowledge, this is the first RCT to evaluate the effectiveness
of a peer‐led intervention to increase exercise participation in patients
with localized PCa. There were 2 important findings: (1) 6 months of a
peer‐led intervention increased the percentage of men meeting suffi-
cient exercise recommendations at 3 months and resistance exercise
participation at 3 and 6 months; and (2) these results were not
sustained at 12 months, and this short‐term increase in exercise was
not accompanied by overall improvements in QoL or psychological
distress.Several studies have reported supervised exercise programs with
resistance exercise to improve physical function, cardiorespiratory
capacity, lean body mass, QoL, and self‐reported physical func-
tion.1,2,8-10 However, these exercise interventions were directly super-
vised by specialists and in most instances undertaken in an exercise
clinic. There is a logical need to enhance dissemination to improve exer-
cise participation inmenwith PCa andmove beyond smaller efficacy tri-
als. Moreover, for those patients unable to access clinic‐based or
supervised sessions, such as those in rural and remote settings, strate-
gies need to be developed to support better access. To date in PCa sur-
vivors, distance‐based physical activity interventions have trialed
tailored print material, telephone counseling, self‐administered imple-
mentation intention, and telephone‐assisted implementation intention
with mixed results.13,14 In our peer‐led intervention, we found an
increase in the percentage of those meeting sufficient exercise recom-
mendations at 3 months and resistance exercise in the short‐term and
medium‐term. Contrary to our original hypotheses, the program was
not effective in increasing aerobic exercise or in improving overall QoL
or psychological distress. These results are similar to a recent report in
76 breast cancer survivors undergoing a short‐term (ie, 12 weeks)
peer‐led intervention program where QoL did not improve despite an
increase in exercise participation.25,26 As with Pinto et al,25,26 there
could have been a ceiling effect in ourmeasures for QoL and psycholog-
ical distress as patients were similar to Australian norms.27,28
Several observational studies have also shown that regular physical
activity has been associated with lower incidence of PCa death.3-6 A
recentobservational studydemonstrated that participation in resistance
exercise 1 day/week was associated with a 33% reduction in overall
mortality rate among ~2900 cancer survivors over a 7‐year follow‐
up.29Of importance, this suggests thatparticipation in a specific exercise
modality (resistance training) may improve overall survival lending early
support for the importance of muscle mass and strength.30 In addition,
supervised resistance exercise specifically in PCa patients undertaking
ADT has been shown to reverse the loss of lean mass, reduce systemic
inflammation, and improve self‐reported and objective measures of
physical function.2,9 Consequently, our findings of increased resis-
tance training participation could be clinically relevant to patients
and in particular to those requiring further systemic therapies (eg,
ADT) that exacerbate treatment related‐toxicities leading to muscu-
loskeletal impairments31 and potentially cardiovascular and metabolic
complications.32,33 Our reported increase in time for resistance exer-
cise participation at 3 and 6 months is quite similar to the results
from the RENEW trial of 18 minutes.13 It may be that men with
PCa have a greater interest in undertaking resistance or strength
training as an exercise modality, possibly viewing it as a more mas-
culine activity compared with aerobic‐basic activities (eg walking).
Nevertheless, although there was a modest increase in the dura-
tion of resistance exercise participation, these gains were not main-
tained at 12 months. Given the peer contact was limited to the initial
6‐month period, further contact after this time may be beneficial in
maintaining resistance exercise, such as every 2 months for the next
6‐month period and then every 3 months for the following 6 months.
Alternatively, as in supervised exercise trials,8 a short‐term contact
period of face‐to‐face instruction where possible or web‐delivered
instruction to enhance exercise self‐efficacy may increase exercise
8 GALVÃO ET AL.participation with reduced frequency of contact thereafter as exercise
habits and confidence become established.344.1 | Study limitations
Our study has several features that are worthy of comment and limita-
tions are noted. Strengths include a large and well‐defined population‐
based cohort that included rural Australian PCa survivors; longer term
follow‐up; and uniquely reporting the impact of peer‐led support on
resistance exercise participation. Limitations of our study include the
absence of a measure of fatigue which often accompanies cancer
treatmentandmayalsobe improvedbyexerciseand theself‐assessment
of exercise. However, it was not feasible to implement objective
measures of exercise given the large number of participants and their
geographical location.
4.2 | Clinical implications
This study provides valuable information on the acceptability and
potential effectiveness of peer‐led interventions in men with PCa in
relation to exercise.We found that a peer‐led intervention for menwith
PCa was effective in increasing patients' resistance exercise participa-
tion in the short‐term to medium‐term. Additional strategies need to
be developed to translate the clinic‐based findings to PCa patients in
the wider community such as a combination of short‐term direct
instruction/supervision followed by technology‐based peer support.
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